Sapient
San Diego
About Sapient
Sapient enables the discovery of circulating small molecule biomarkers at unprecedented speed and scale. Leveraging next-generation mass spectrometry, biocomputational analysis, and large-scale human biology databases, its platform supports the rapid identification and validation of circulating biomarkers of health, disease, and drug response which are needed to align patients, disease biology, and specific therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $13.8M
- Last round: Grant (Jul 2022)
- Website: sapient.bio
- Phone: +1 858 290 7010
Industries & Categories
Biotechnology, Clinical Trials, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sapient-34321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.